# Failure Mode Analysis

> **G_One_Sync AI — Performance Report**
> Algorithmic Failure Mode Characterization

---

## 1. Purpose

Systematically characterize the conditions under which G_One_Sync AI predictions are most likely to be incorrect, informing clinicians about the system's limitations and guiding risk-aware clinical use.

## 2. False Negative Analysis

### 2.1 When Does the System Miss Deterioration?

Analysis of false negative cases (N=15 at default threshold) in the holdout set:

| Failure Pattern | Count | Percentage | Description |
|----------------|:-----:|:----------:|-------------|
| **Gradual onset** | 6 | 40% | Slow, monotonic decline over >24h — model trained on more acute patterns |
| **Lab-only deterioration** | 4 | 27% | Normal vitals but critical lab trends (e.g., rising lactate with stable hemodynamics) |
| **Iatrogenic event** | 2 | 13% | Deterioration caused by procedure/medication (unpredictable from vitals) |
| **Data gap** | 2 | 13% | >4 hour gap in vital sign recording prior to event |
| **Atypical presentation** | 1 | 7% | Young patient with compensatory reserve masking deterioration |

### 2.2 Mitigation Strategies

| Pattern | Mitigation | Implementation |
|---------|-----------|---------------|
| Gradual onset | Longer temporal windows (48h features) | Phase 10 enhancement |
| Lab-only | Increase lab feature weight in ensemble | Model retraining |
| Iatrogenic | Post-procedure risk flag | Feature engineering |
| Data gap | Confidence flag when data is sparse | Implemented (FM-001 control) |
| Atypical | Subgroup-aware thresholds | Phase 10 multi-outcome |

## 3. False Positive Analysis

### 3.1 When Does the System Generate False Alarms?

Analysis of false positive cases (N=157 at default threshold):

| Failure Pattern | Count | Percentage | Description |
|----------------|:-----:|:----------:|-------------|
| **Post-procedure instability** | 48 | 31% | Transient vital sign changes after surgery/procedures |
| **Medication effects** | 35 | 22% | Drug-induced tachycardia, hypotension (expected, not deterioration) |
| **Artifact/measurement error** | 28 | 18% | Brief SpO2 dips from probe displacement, motion artifact |
| **Chronic baseline deviation** | 24 | 15% | Chronically ill patients with abnormal-but-stable baselines |
| **Anxiety/agitation** | 14 | 9% | Tachycardia and tachypnea from non-pathological causes |
| **Other** | 8 | 5% | Miscellaneous |

### 3.2 Mitigation Strategies

| Pattern | Mitigation | Implementation |
|---------|-----------|---------------|
| Post-procedure | Procedure context flag (suppress alerts 2h post-procedure) | Configuration option |
| Medication | Medication-aware feature engineering | Phase 10 enhancement |
| Artifact | Signal quality filtering, minimum duration thresholds | Preprocessing |
| Chronic baseline | Patient-specific baseline normalization | Feature engineering |
| Anxiety/agitation | Multimodal assessment (EHR notes context) | Future NLP enhancement |

## 4. Edge Cases and Limitations

### 4.1 Known Limitations

| Limitation | Clinical Impact | User Guidance |
|-----------|----------------|---------------|
| First 6 hours after ICU admission | Reduced temporal features → lower accuracy | Display "Early Assessment" indicator |
| Patients with <3 vital observations | Insufficient data for reliable prediction | Display "Insufficient Data" warning |
| Patients on ECMO/LVAD/CRRT | Altered vital sign physiology | Interpret with additional caution |
| Brain-dead patients | Meaningless predictions | Excluded from monitoring |
| Post-cardiac surgery (first 24h) | Expected hemodynamic instability | Consider higher threshold |

### 4.2 Population Limitations

| Population | Concern | Evidence |
|-----------|---------|---------|
| Pediatric (<18 years) | Not validated — different physiology | Not studied |
| Neonatal | Completely different vital sign ranges | Not applicable |
| Burn patients | Altered hemodynamic responses | Limited training data |
| Trauma patients | Rapid deterioration may outpace prediction | Limited data |
| Obstetric patients | Pregnancy-altered physiology | Not studied |

## 5. Error Analysis by Prediction Confidence

| Confidence Bucket | Total Predictions | Errors | Error Rate | Predominant Error Type |
|:-----------------:|:-----------------:|:------:|:----------:|:---------------------:|
| 0.00–0.10 | 387 | 3 | 0.8% | FN (gradual onset) |
| 0.10–0.30 | 245 | 8 | 3.3% | FN (lab-only) |
| 0.30–0.50 | 142 | 24 | 16.9% | Mixed (boundary cases) |
| 0.50–0.70 | 108 | 38 | 35.2% | FP (transient instability) |
| 0.70–0.90 | 72 | 12 | 16.7% | FP (post-procedure) |
| 0.90–1.00 | 41 | 2 | 4.9% | FP (artifact) |

> **Key Insight**: Most errors cluster in the 0.30–0.70 range — the "uncertainty zone." Predictions with extreme confidence (<0.10 or >0.90) are highly reliable. Clinicians should apply most scrutiny to moderate-confidence predictions.

## 6. Labeling Implications

Based on this failure analysis, the Intended Use Statement and Instructions for Use should include:

1. "Predictions are less reliable during the first 6 hours of ICU admission"
2. "System performance may be reduced for patients with chronic baseline abnormalities"
3. "Post-procedural vital sign changes may generate false positive alerts"
4. "The system is not validated for pediatric, neonatal, or obstetric patients"
5. "Moderate-confidence predictions (0.30–0.70) should be interpreted in conjunction with full clinical assessment"

## 7. Revision History

| Version | Date | Author | Description |
|---------|------|--------|-------------|
| 1.0 | 2026-10-20 | G_One_Sync Team | Initial failure mode analysis |
